Skip to content

A randomized controlled study of the clinical efficacy and safety of preoperative CT chest angiography in the treatment of hemoptysis by bronchial arterial embolization

A randomized controlled study of the clinical efficacy and safety of preoperative CT chest angiography in the treatment of hemoptysis by bronchial arterial embolization

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030206
Enrollment
Unknown
Registered
2020-02-25
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemoptysis

Interventions

experimental group:traditional BAE combined with preoperative CTA
control group:traditional BAE

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with massive hemoptysis whose hemoptysis volume per session exceeds 100ml or whose maximum daily hemoptysis volume exceeds 300ml; 2. Patients with minor-medium amount of hemoptysis whose hemoptysis volume is not up to the above standards for large hemoptysis, but whose condition is still repeated within a week after general medical treatment and the patient has the intention of an intervention operation.

Exclusion criteria

Exclusion criteria: 1. Lung malignant tumor highly suspected or confirmed clinically; 2. Lung damage caused by tuberculosis or other causes; 3. emergency intervention for hemostasis is required due to poor efficacy of conservative medical treatment.

Design outcomes

Primary

MeasureTime frame
Early hemoptysis control rate;Dose and duration of patients' radiation exposure;Dose and duration of physician's radiation exposure;

Secondary

MeasureTime frame
Immediate hemostatic success rate;hemoptysis-free time;Long-term hemoptysis control rate;Incidence of hemoptysis during preoperative evaluation;The mortality of hemoptysis during preoperative evaluation;The operation time;

Countries

China

Contacts

Public ContactLuo Fengming
luofengming@hotmail.com+86 18980601355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026